Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

Spontaneous heparin-induced thrombocytopenia syndrome presenting as bilateral adrenal infarction after knee arthroplasty.

VanderVeer EA, Torbiak RP, Prebtani AP, Warkentin TE.

BMJ Case Rep. 2019 Dec 29;12(12). pii: e232769. doi: 10.1136/bcr-2019-232769.

2.

Serotonin-release assay-negative heparin-induced thrombocytopenia.

Warkentin TE, Nazy I, Sheppard JI, Smith JW, Kelton JG, Arnold DM.

Am J Hematol. 2020 Jan;95(1):38-47. doi: 10.1002/ajh.25660. Epub 2019 Nov 6.

PMID:
31621093
3.

Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation.

Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M; Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis.

J Thromb Haemost. 2019 Nov;17(11):1989-1994. doi: 10.1111/jth.14578. Epub 2019 Aug 13. No abstract available.

PMID:
31410983
4.

Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.

Manji F, Warkentin TE, Sheppard JI, Lee A.

Platelets. 2020;31(1):124-127. doi: 10.1080/09537104.2019.1652263. Epub 2019 Aug 9.

PMID:
31397594
5.

Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy?

Levy JH, Ghadimi K, Faraoni D, van Diepen S, Levy B, Hotchkiss R, Connors JM, Iba T, Warkentin TE.

J Thromb Haemost. 2019 Nov;17(11):1973-1978. doi: 10.1111/jth.14566. Epub 2019 Jul 23. No abstract available.

PMID:
31334603
6.

High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.

Warkentin TE.

Expert Rev Hematol. 2019 Aug;12(8):685-698. doi: 10.1080/17474086.2019.1636645. Epub 2019 Jul 5.

PMID:
31274032
7.

Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation.

Iba T, Levy JH, Raj A, Warkentin TE.

J Clin Med. 2019 May 22;8(5). pii: E728. doi: 10.3390/jcm8050728. Review.

8.

Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation.

Iba T, Levy JH, Yamakawa K, Thachil J, Warkentin TE, Levi M; Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis.

J Thromb Haemost. 2019 Aug;17(8):1265-1268. doi: 10.1111/jth.14482. Epub 2019 Jun 5. No abstract available.

PMID:
31099127
9.

Laboratory diagnosis of heparin-induced thrombocytopenia.

Warkentin TE.

Int J Lab Hematol. 2019 May;41 Suppl 1:15-25. doi: 10.1111/ijlh.12993. Review.

PMID:
31069988
10.

Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay.

Warkentin TE, Sheppard JI, Smith JW, Arnold DM, Nazy I.

Int J Lab Hematol. 2019 Aug;41(4):493-502. doi: 10.1111/ijlh.13031. Epub 2019 May 3.

11.

Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia.

Hui M, Sheppard JI, Li N, Warkentin TE.

Thromb Haemost. 2019 Jun;119(6):941-951. doi: 10.1055/s-0039-1683913. Epub 2019 Apr 20.

PMID:
31005061
12.

The association between platelet transfusions and mortality in patients with critical illness.

Ning S, Liu Y, Barty R, Cook R, Rochwerg B, Iorio A, Warkentin TE, Heddle NM, Arnold DM.

Transfusion. 2019 Jun;59(6):1962-1970. doi: 10.1111/trf.15277. Epub 2019 Apr 1.

PMID:
30934133
13.

Autoimmune heparin-induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin.

Arcinas LA, Manji RA, Hrymak C, Dao V, Sheppard JI, Warkentin TE.

Transfusion. 2019 Jun;59(6):1924-1933. doi: 10.1111/trf.15263. Epub 2019 Mar 23.

PMID:
30903805
14.

High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.

Mohanty E, Nazir S, Sheppard JI, Forman DA, Warkentin TE.

J Thromb Haemost. 2019 May;17(5):841-844. doi: 10.1111/jth.14411. Epub 2019 Mar 14.

PMID:
30773806
15.

An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia.

Eekels JJM, Althaus K, Bakchoul T, Kroll H, Kiefel V, Nazy I, Lee LS, Sachs U, Warkentin TE, Greinacher A.

J Thromb Haemost. 2019 Mar;17(3):525-531. doi: 10.1111/jth.14383. Epub 2019 Feb 20.

PMID:
30640980
16.

Microvascular Thrombosis and Ischaemic Limb Losses in Critically Ill Patients.

Warkentin TE.

Hamostaseologie. 2019 Feb;39(1):6-19. doi: 10.1055/s-0038-1676823. Epub 2019 Jan 9. Review.

PMID:
30625509
17.

Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH.

Iba T, Levy JH, Wada H, Thachil J, Warkentin TE, Levi M; Subcommittee on Disseminated Intravascular Coagulation.

J Thromb Haemost. 2019 Feb;17(2):415-419. doi: 10.1111/jth.14354. Epub 2019 Jan 7. No abstract available.

PMID:
30618150
18.

Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.

Krauel K, Preuße P, Warkentin TE, Trabhardt C, Brandt S, Jensch I, Mandelkow M, Hammer E, Hammerschmidt S, Greinacher A.

Blood. 2019 Feb 28;133(9):978-989. doi: 10.1182/blood-2018-05-850370. Epub 2018 Dec 20.

PMID:
30573633
19.

Natural, not immune; classical, not alternative.

Warkentin TE.

Blood. 2018 Dec 6;132(23):2421-2422. doi: 10.1182/blood-2018-10-880799. No abstract available.

PMID:
30523121
20.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N.

Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489.

21.

Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials.

Linkins LA, Hu G, Warkentin TE.

Res Pract Thromb Haemost. 2018 Aug 9;2(4):678-683. doi: 10.1002/rth2.12145. eCollection 2018 Oct.

22.

Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA.

Warkentin TE, Morin PA, Heddle NM.

Transfusion. 2018 Oct;58(10):2320-2325. doi: 10.1111/trf.14894. Epub 2018 Sep 4.

PMID:
30178875
23.

Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene.

Warkentin TE.

J Thromb Haemost. 2018 Nov;16(11):2128-2132. doi: 10.1111/jth.14264. Epub 2018 Sep 8.

PMID:
30099843
24.

High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT.

Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I.

Blood. 2018 Sep 20;132(12):1345-1349. doi: 10.1182/blood-2018-04-847483. Epub 2018 Jul 31. No abstract available.

25.

Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report.

Tan JH, Mohamad Y, Tan CLH, Kassim M, Warkentin TE.

J Med Case Rep. 2018 May 19;12(1):131. doi: 10.1186/s13256-018-1684-1.

26.

Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia.

Warkentin TE, Climans TH, Morin PA.

N Engl J Med. 2018 May 10;378(19):1845-1848. doi: 10.1056/NEJMc1801799. No abstract available.

PMID:
29742374
27.

Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.

Nazy I, Clare R, Staibano P, Warkentin TE, Larché M, Moore JC, Smith JW, Whitlock RP, Kelton JG, Arnold DM.

J Thromb Haemost. 2018 Jul;16(7):1402-1412. doi: 10.1111/jth.14132. Epub 2018 Jun 5.

PMID:
29723924
28.

Acute haemolysis, DIC and renal failure after transfusion of uncross-matched blood during trauma resuscitation: illustrative case and literature review.

Fiorellino J, Elahie AL, Warkentin TE.

Transfus Med. 2018 Aug;28(4):319-325. doi: 10.1111/tme.12513. Epub 2018 Feb 19. Review.

PMID:
29460456
29.

Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.

Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I.

Chest. 2018 Jun;153(6):1396-1404. doi: 10.1016/j.chest.2018.01.001. Epub 2018 Jan 8.

PMID:
29325985
30.

Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia: Too Good to Be True?

Warkentin TE.

J Am Coll Cardiol. 2017 Nov 28;70(21):2649-2651. doi: 10.1016/j.jacc.2017.09.1098. No abstract available.

31.

Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial.

Cook RJ, Heddle NM, Lee KA, Arnold DM, Crowther MA, Devereaux PJ, Ellis M, Figueroa P, Kurz A, Roxby D, Sessler DI, Sharon Y, Sobieraj-Teague M, Warkentin TE, Webert KE, Barty R, Liu Y, Eikelboom JW.

Lancet Haematol. 2017 Nov;4(11):e544-e552. doi: 10.1016/S2352-3026(17)30169-2. Epub 2017 Oct 8.

PMID:
29021123
32.

IV Immunoglobulin for Autoimmune Heparin-Induced Thrombocytopenia.

Ning S, Warkentin TE.

Chest. 2017 Sep;152(3):453-455. doi: 10.1016/j.chest.2017.05.042. No abstract available.

PMID:
28889872
33.

Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.

Poudel DR, Ghimire S, Dhital R, Forman DA, Warkentin TE.

Platelets. 2017 Sep;28(6):614-620. doi: 10.1080/09537104.2017.1366973. Epub 2017 Aug 31. Review.

PMID:
28856946
34.

Autoimmune heparin-induced thrombocytopenia.

Greinacher A, Selleng K, Warkentin TE.

J Thromb Haemost. 2017 Nov;15(11):2099-2114. doi: 10.1111/jth.13813. Epub 2017 Sep 28. Review.

35.

Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.

Shih AW, Sheppard JI, Warkentin TE.

Thromb Haemost. 2017 Oct 5;117(10):1868-1874. doi: 10.1160/TH17-03-0212. Epub 2017 Aug 24. Review.

PMID:
28837208
36.

B cells, PF4/heparin complexes, and complement.

Warkentin TE.

Blood. 2016 Oct 6;128(14):1781-1782. doi: 10.1182/blood-2016-08-729517. No abstract available.

PMID:
28832327
37.

Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma.

Mian H, Warkentin TE, Sheppard JI, MacDonald A, Linkins LA, Benger A, Foley R.

Blood. 2017 Oct 5;130(14):1679-1682. doi: 10.1182/blood-2017-06-788679. Epub 2017 Aug 22. No abstract available.

PMID:
28830891
38.

Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature.

Ezekwudo DE, Chacko R, Gbadamosi B, Batool S, Gaikazian S, Warkentin TE, Sheppard JI, Jaiyesimi I.

Exp Hematol Oncol. 2017 Jul 14;6:21. doi: 10.1186/s40164-017-0080-7. eCollection 2017.

39.

Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.

Warkentin TE, Pai M, Linkins LA.

Blood. 2017 Aug 31;130(9):1104-1113. doi: 10.1182/blood-2017-04-778993. Epub 2017 Jun 23. Review.

PMID:
28646118
40.

Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.

Raschke RA, Gallo T, Curry SC, Whiting T, Padilla-Jones A, Warkentin TE, Puri A.

J Thromb Haemost. 2017 Aug;15(8):1640-1645. doi: 10.1111/jth.13758. Epub 2017 Jul 17.

41.

Levofloxacin-Induced Acute Immune-Mediated Thrombocytopenia of Rapid-Onset.

Shih AW, Lam AS, Warkentin TE.

J Pharm Pract. 2018 Apr;31(2):234-237. doi: 10.1177/0897190017702306. Epub 2017 Apr 13.

PMID:
28403679
42.

Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL® HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia.

Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I.

Thromb Res. 2017 May;153:108-117. doi: 10.1016/j.thromres.2017.03.010. Epub 2017 Mar 11.

43.

Diagnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis.

Husseinzadeh HD, Gimotty PA, Pishko AM, Buckley M, Warkentin TE, Cuker A.

J Thromb Haemost. 2017 Jun;15(6):1203-1212. doi: 10.1111/jth.13692. Epub 2017 May 11. Review.

44.

Sepsis and persisting neutropenia in a drug addict.

Shapiro RM, Zeller MP, Warkentin TE.

Am J Hematol. 2017 Mar;92(3):312-316. doi: 10.1002/ajh.24639. Epub 2017 Feb 3. No abstract available.

45.

How do we approach thrombocytopenia in critically ill patients?

Thachil J, Warkentin TE.

Br J Haematol. 2017 Apr;177(1):27-38. doi: 10.1111/bjh.14482. Epub 2016 Dec 16. Review.

PMID:
27982413
46.

Heparin-induced thrombocytopenia in 2017 and beyond.

Bakchoul T, Greinacher A, Warkentin TE.

Thromb Haemost. 2016 Oct 28;116(5):781-782. Epub 2016 Oct 13. No abstract available.

PMID:
27734071
47.

Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia.

Warkentin TE.

Thromb Haemost. 2016 Oct 28;116(5):813-822. Epub 2016 Sep 22.

PMID:
27656712
48.

Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion.

Heddle NM, Cook RJ, Arnold DM, Liu Y, Barty R, Crowther MA, Devereaux PJ, Hirsh J, Warkentin TE, Webert KE, Roxby D, Sobieraj-Teague M, Kurz A, Sessler DI, Figueroa P, Ellis M, Eikelboom JW.

N Engl J Med. 2016 Nov 17;375(20):1937-1945. Epub 2016 Oct 24.

49.

Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is 'shock liver' the unrecognized provocateur of ischemic limb necrosis: reply.

Warkentin TE, Pai M.

J Thromb Haemost. 2016 Nov;14(11):2317-2319. doi: 10.1111/jth.13498. Epub 2016 Oct 19. No abstract available.

50.

Acute intraoperative HIT during heart surgery: Why so rare?

Warkentin TE.

Thromb Res. 2016 Oct;146:110-112. doi: 10.1016/j.thromres.2016.09.005. Epub 2016 Sep 12. No abstract available.

PMID:
27640328

Supplemental Content

Loading ...
Support Center